Table 2.
Bruxism Index across time points
| Baseline | Active phase | Placebo phase | |||
| 4 weeks | 12 weeks | 4 weeks | 12 weeks | ||
| Mean±SD | 8.29±2.88 | 6.67±4.09 | 7.38±3.55 | 8.33±4.11 | 7.67±3.50 |
| Min–Max | 5.13–15.8 | 2.75–22.6 | 3.13–15.6 | 3.20–22.1 | 2.80–15.0 |
Bruxism Index across time points
| Baseline | Active phase | Placebo phase | |||
| 4 weeks | 12 weeks | 4 weeks | 12 weeks | ||
| Mean±SD | 8.29±2.88 | 6.67±4.09 | 7.38±3.55 | 8.33±4.11 | 7.67±3.50 |
| Min–Max | 5.13–15.8 | 2.75–22.6 | 3.13–15.6 | 3.20–22.1 | 2.80–15.0 |